Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

NCT02581345 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

572

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis
Psoriasis

Interventions

BIOLOGICAL: M923
BIOLOGICAL: Humira

Sponsor

Momenta Pharmaceuticals, Inc.